Nestled in the foothills of the San Gabriel Mountains, Beckman Research Institute was the first of five Beckman Institutes to be founded. The Beckman Institute at City of Hope is unique because it has held a National Cancer Institute Cancer Center Support Grant for more than 30 years.
It encompasses over 60 years of expertise in basic science that includes research at City of Hope prior to the establishment of the Institute by Arnold and Mabel Beckman in 1983. Faculty and investigators here revolutionize the treatment of life-threatening diseases. They are focused on investigating the biology, biological chemistry, and pathology of cancer and diabetes, and they examine the emerging links between the two. Researchers are committed to identifying opportunities at the cellular and molecular level to predict, prevent, diagnose, treat and cure these and other serious diseases.
Fundamental advances in understanding of acute illnesses translate into an improved armamentarium for clinicians at City of Hope, which for 10 years has been ranked a U.S.News & World Report Best Cancer Hospital.
Beckman Research Institute investigators examine a wide range of research areas that includes diabetes progression and treatment, immunology and imaging, interfering RNAs and HIV treatment, total synthesis of complex and therapeutic natural products, mechanisms of drug action, neurogenesis, DNA repair and radiation, and the immunobiology of viral infection.
In addition, the City of Hope NCI-Designated Comprehensive Cancer Center is comprised of five research programs in the areas of basic, translational, and prevention research: Cancer Biology, Developmental Cancer Therapeutics, Cancer Immunotherapeutics, Hematologic Malignancies, and Cancer Control & Population Sciences. These programs conduct activities across the entire Duarte campus facilitating interactions among researchers and clinicians of all disciplines.
Dedicated to discovering immune-based cancer therapies, the Department of Cancer Immunotherapeutics & Tumor Immunology conducts research in a new and evolving field and is known particularly for its studies using genetically engineered T-cells.
This department focuses on understanding the genetic and molecular bases of diabetes, developing novel treatment approaches for diabetes and preventing associated diseases such as cancer, heart disease and stroke.
Division of Molecular Diabetes Research
The Division of Molecular Diabetes Research is at the forefront of research on the complications of diabetes and was the first to study epigenetic changes in diabetic complications.
Maintaining a strong emphasis on the interface of chemistry and biology, the Department of Molecular and Cellular Biology focuses on gene structure, modeling of antibodies, theoretical biology and more.
The Department of Neurosciences focuses on a range of research related to the brain and nervous system, including studies of molecular neurobiology/neurochemistry, neurophysiology, neuromorphology and molecular genetics.
Department researchers collaborate to better understand the causes of cancer, improve outcomes and develop ways to prevent cancer through discoveries made in population studies, survivorship, patterns of care and more.
Division of Cancer Etiology
The goal of the Division of Cancer Etiology is to understand the causes of cancer. By understanding the causes of cancer, solutions can be developed to help prevent cancer, especially in people who are at highest risk.
Division of Clinical Cancer Genetics
The Division of Clinical Cancer Genetics includes clinical services, research, and educational programs focusing on people who are at increased risk for developing cancer because of family history or personal risk factors.
Division of Outcomes Research
The goal of the Division of Outcomes Research is to better understand the after-effects (physical, emotional, and social) of cancer and its treatment.
Center for Cancer Survivorship
This is a clinical long-term follow-up program designed to create a bridge between cancer treatment and community medical care.
Division of Nursing Research and Education
The Division of Nursing Research and Education is well recognized on a national level for its research and education focused on nursing care for patients with cancer, which has helped to increase the quality of care provided to cancer patients across the United States.
Research in the Department of Virology supports eight faculty members and laboratories with research including viral vector development, viral immunology, and vaccine development. The program includes early phase clinical trials in gene transfer and in vaccine evaluation.
Translational Vaccine Research
The Division of Translational Vaccine Research (TVR) develops vaccines to combat hematologic malignancies, solid tumors, and infectious pathogens such as CMV and HIV.
Arthur Riggs, Ph.D., and Shmuel Cabilly, Ph.D., demonstrate the feasibility and describe a method for making humanized monoclonal antibodies, technology later used in “smart” cancer drugs such as Herceptin, Rituxan and Avastin.
Eugene Roberts, Ph.D., is elected to the National Academy of Sciences in recognition of his work on the existence and function of GABA and other neurotransmitters on the brain and nervous system.
John Rossi, Ph.D., reports first use of RNA to block the progress of the virus that causes AIDS.
The Graduate School of Biological Sciences is chartered.
The Division of Molecular Medicine is created.
Gerd Pfeifer, Ph.D., definitively links smoking to lung cancer, identifying the genetic damage done by the active compounds in cigarettes.
The Division of Molecular Biology is created.
Barry Forman, M.D., Ph.D., identifies the first new steroid-like hormone in 30 years, androstanol, a hormone that reverses or halts gene activity.
The Division of Virology is created.
Arthur Riggs, Ph.D., is named Director of the Beckman Research Institute.
The Center for Biomedicine & Genetics is established to ensure that
City of Hope
scientific discoveries are efficiently translated from the research lab to the clinical setting.
These milestones outline how Beckman Research Institute of
City of Hope
has grown to become one of the nation’s premier centers for innovative biomedical research, advancing the fundamental understanding of molecular genetics, cellular biology and more.
The Research Institute is dedicated
The Division of Neurosciences is created.
The Division of Biology is created.
The Division of Immunology is created.
The Bone Marrow Transplantation Program is initiated, making City of Hope one of the first of six medical centers in the nation to perform this lifesaving procedure.
Ernest Beutler, M.D., is elected to the National Academy of Sciences in recognition of his research on the genetics of hematological diseases.
Arthur Riggs, Ph.D., and Keiichi Itakura, Ph.D., synthesize the human insulin gene resulting in the production of Humulin®, a pure source of human insulin available to people with diabetes.
Keiichi Itakura, Ph.D., and Arthur Riggs, Ph.D., pioneer the recombinant DNA techniques used to synthesize human growth hormone, enabling thousands of undersized youngsters to reach near-normal height.
The National Cancer Institute awards the first in a series of major grants to City of Hope’s Bone Marrow Transplantation Program.
Susumu Ohno, D.V.M., Ph.D., is elected to the National Academy of Sciences in recognition of his work on X chromosome inactivation and his theory of evolution by gene duplication.
Yoko Fujita-Yamaguchi, Ph.D., purifies the insulin receptor molecule.
Every field has its stars, and nursing research is certainly no exception. One of those stars – City of Hope’s Betty Ferrel, Ph.D., R.N., – will soon be inducted into the International Nurse Researcher Hall of Fame by the Honor Society of Nursing, Sigma Theta Tau International (STTI). A pioneer in the...
Bladder cancer incidence rates have not increased over the past few years — which is a good thing. But unlike cancers of the colon, prostate and lung, they haven’t declined either. With more than 74,690 new cases of bladder cancer diagnosed in the United States each year and approximately 15, 580 deaths from...
When Ralph Richardson discovered that his prostate-specific antigen (PSA) reading was a 6, he told his primary care physician that he wanted to go to City of Hope. “I felt I was better off in a City of Hope environment, where it’s a cancer treatment specialty hospital. This is what they do,” Richardson said....
A new test that allows researchers to quickly identify drugs and chemicals that could disrupt the balance of hormones in the body – potentially affecting development and progression of cancer, including breast cancer – has raised worries about the common antidepressant Paxil. In a trial screening of 446 comm...
No matter how impressive a research study’s conclusion may be – or how seemingly unsurprising – experts are needed to put the findings into context. Perhaps a study’s methodology wasn’t as strong as it could have been. Perhaps the conclusions confirmed that other researchers are on the right track. Perhaps t...
Research studies known as clinical trials have led to countless advances in the diagnosis, treatment and prevention of cancer. These studies test the effectiveness of new medical approaches that can lead to fewer treatment-related side effects and, in some cases, improved outcomes for patients with certain c...
Many cancer incidence rates decline over time, but kidney cancer is one of the few cancers with incidence rates that continue to rise year after year. Currently, nearly 64,000 new cases of kidney cancer are diagnosed in the United States each year, and approximately 13,860 people die from it, according to t...
Once unknown to most people, HPV, or human papillomavirus, has become a subject of both worry and debate. It’s directly linked to cervical cancer, head and neck and other cancers, but many parents are reluctant to vaccinate their daughters against the disease. City of Hope’s recent “Ask the...
Parenting a child isn’t easy. Parenting a child with cancer can be infinitely more difficult. But parents can’t give up on their basic responsibilities to raise a child properly. In this video, Jeanelle Folbrecht, Ph.D., associate clinical professor of psychology in the Department of Supportive Care Medicine...
When it comes to working out, harder and faster may not always be better. That’s what Sophia Wang, Ph.D., associate professor at City of Hope’s Department of Population Sciences, found about exercise and stroke risk when she looked into the connection between the two. Examining data from more tha...
An epidemic of thyroid cancer in the U.S. is actually an epidemic of diagnosis, conclude the authors of a new report. Their analysis pointed out that, although thyroid cancer diagnoses have nearly tripled during the past 30 years, mortality rates have remained the same. To them, this means the disease has be...
After adjusting to the rigors of a cancer patient’s schedule – a barrage of appointments with surgeons, oncologists, radiologists, chemotherapy treatments, surgeries, tests – cancer survivors have large adjustments to make. “You get into this system where you’re seeing multiple doctors a week – you’re in a g...
A friend’s child has been hospitalized for cancer treatment. You want to visit, but don’t know what to say. You want to help, but don’t know what to do. City of Hope has some advice. In this video series, Jeanelle Folbrecht, Ph.D., associate clinical professor of psychology in the Department of Supportive Ca...
A side effect of cancer treatment many people don’t expect? Weight gain. People with certain cancers – such as breast, prostate and colon cancer – are more likely to gain weight during treatment due to the therapies used to combat their disease. Hormone therapy, some chemotherapy regimens and medications suc...
Humans are exposed to countless chemicals every day, so identifying the ones that can impact their health – specifically the ones that can increase cancer risk – is akin to looking for a sugar crystal in a salt shaker. But that process has now been made much less arduous by researchers at City of Hope. They&...